To explore the effect of ezrin on PALM2-mediated ESCC cell migration, ezrin knockout KYSE450 cells were constructed using CRISPR/Cas9 technology, and two monoclonal cell lines were successfully obtained (Fig. 6A). The gene discussed is PALM2AKAP2; the disease is esophageal squamous cell carcinoma.